ArticleInternational journal of molecular sciences2025

Clinical Implications of Point-of-Care Measurement of Adalimumab Concentration and Anti-Adalimumab Antibodies in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.

Jiyeol Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.